This article is educational and is not medical advice. It explains what the marker measures, what typical and optimal ranges look like, what moves the number, and what is worth raising with a clinician.
Triglycerides are the main form in which your body stores and transports fat, three fatty acids attached to a glycerol backbone. Almost all the fat you eat arrives as triglyceride, and almost all the fat stored in adipose tissue is held in the same form.
After a meal, the gut packages dietary fat into chylomicrons and releases them into circulation. The liver separately packages fat into VLDL particles, drawing on fatty acids from the diet, from body fat stores, and from fat it manufactures itself out of surplus carbohydrate and alcohol. Both particle types carry triglyceride to muscle for fuel and to fat tissue for storage, where an enzyme called lipoprotein lipase unloads them at the vessel wall.
A blood triglyceride measurement is a snapshot of how much of this cargo is circulating at the moment the sample is drawn. That makes it a flow measurement rather than a stock measurement. It reflects the balance between how much fat is entering the bloodstream (from the gut and the liver) and how fast tissues are clearing it. When either side of that balance shifts, which happens with a large meal, a drinking session, weight gain, or insulin resistance, the number moves quickly. Few routine biomarkers are as responsive to recent behaviour.
Elevated triglycerides matter because the particles carrying them, and the cholesterol-rich remnants left behind as they are broken down, are independently associated with cardiovascular risk. For years triglycerides were treated as a secondary number next to LDL cholesterol. That view has shifted substantially.
Large reviews describe triglyceride-rich lipoproteins and their remnants as contributors to atherosclerosis rather than innocent bystanders[1], and clinical reviews place elevated triglycerides among the residual risk factors that persist even when LDL cholesterol has been brought down[2]. Genetic analyses using inherited variation as a natural experiment suggest the relationship with remnant cholesterol and triglycerides is causal rather than merely correlational, and that it extends to clustered cardiometabolic conditions rather than heart disease alone[3].
There are plausible mechanisms behind the association. Research links triglyceride-rich lipoproteins to impaired endothelial function, meaning the inner lining of blood vessels behaves less well[4], and more recent work has examined inflammatory signatures in immune cells of people with high triglycerides[5].
There is a second reason to pay attention. A markedly elevated triglyceride level is associated with risk of pancreatitis, which is why very high readings are worth discussing with a clinician promptly rather than waiting for a routine follow-up.
Most laboratories report fasting triglycerides as acceptable anywhere up to roughly 150 mg/dL, while optimization targets sit considerably lower.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Fasting triglycerides | 30 to 150 mg/dL | 50 to 80 mg/dL |
FitScript's optimal range is an optimization target, not a diagnostic cut-off. A value outside it is not a diagnosis and does not mean something is wrong, it means there may be room to move.
Alongside the laboratory range, these widely used clinical categories are helpful context for fasting values.
| Category | Fasting triglycerides |
|---|---|
| Normal | Below 150 mg/dL |
| Borderline high | 150 to 199 mg/dL |
| High | 200 to 499 mg/dL |
| Very high | 500 mg/dL and above |
Reference ranges vary by laboratory, by assay, and to some degree by age and sex, so always read your result against the range printed on your own report. Some laboratories report in mmol/L instead; dividing mg/dL by roughly 88.5 gives the approximate mmol/L figure, so 150 mg/dL is close to 1.7 mmol/L.
The gap between "within range" and "optimal" is where most of the practical conversation happens. A reading of 140 mg/dL passes as normal on paper, yet sits well above the range associated with good metabolic flexibility, and it often travels with other findings worth looking at together.
An elevated triglyceride result most often reflects some combination of energy surplus, insulin resistance, alcohol intake, and recent eating, rather than a single cause.
The most common pattern is metabolic. When cells respond poorly to insulin, fat tissue releases more fatty acids into circulation and the liver repackages them into VLDL. At the same time, insulin resistance reduces the activity of the enzyme that clears triglyceride from the blood, so production rises while clearance falls. Reviews of the marker describe this dual mechanism as the usual explanation for moderately raised values[6]. This is why raised triglycerides so often appear next to a low HDL cholesterol, a rising fasting glucose, and increased waist circumference, the cluster that clinicians recognise as metabolic syndrome[7].
Other contributors include a high intake of refined carbohydrate or added sugar (particularly fructose, which the liver converts readily into fat), alcohol, significant weight gain, poorly controlled blood sugar, reduced thyroid function, kidney disease, certain medications, pregnancy, and inherited lipid disorders. Very high values, especially above the range where pancreatitis risk rises, more often involve a genetic component alongside a lifestyle trigger.
One result on its own does not establish any of this. It is an observation. What it may reflect depends on the rest of your panel, your history, and whether the finding repeats on a second test.
Yes, although it is far less common and usually less consequential than a high reading. A very low triglyceride value can simply reflect a lean, active person with a low-fat recent intake, which is unremarkable.
When a low result is genuinely unusual, it can accompany malnutrition, prolonged very low calorie intake, malabsorption conditions such as coeliac disease, an overactive thyroid, or rare inherited disorders of lipoprotein production. In those situations the low triglyceride is rarely the only clue; low total cholesterol, low body weight, deficiencies in fat-soluble vitamins, or digestive symptoms usually appear alongside it.
Because the marker tracks recent intake so closely, a single low value in someone who has been eating very little before the draw tells you little on its own. The useful question is whether the value is low repeatedly, whether other markers are drifting in the same direction, and whether there are symptoms. That combination, rather than the isolated number, is what a clinician interprets.
Reducing refined carbohydrate, added sugar and overall calorie surplus usually moves triglycerides faster than any other dietary change.
The mechanism is direct. Surplus carbohydrate, particularly fructose from sweetened drinks, sweets and many processed foods, is converted by the liver into fatty acids and exported as VLDL. Cutting the surplus removes the raw material. In practice, the single highest-yield change for many people is eliminating sugar-sweetened beverages, because liquid sugar arrives quickly, is easy to overconsume, and contributes nothing that creates fullness.
Several other adjustments reliably help.
Total fat intake matters less than most people expect once calories and carbohydrate quality are under control. Very low fat diets can even raise triglycerides in some people if the displaced calories come back as refined carbohydrate. The pattern that works is usually unglamorous, mostly whole foods, adequate protein, plenty of fibre, limited added sugar, and portions that match your actual activity level.
For some people alcohol is the single largest contributor, and reducing it produces a faster change than any food swap.
Alcohol is metabolised almost entirely by the liver, and that process shifts the liver towards making and exporting fat. Reviews of the relationship describe alcohol intake as a consistent influence on plasma triglyceride levels, with the effect depending on the amount consumed, the drinking pattern, and the individual's baseline lipid state[8]. People who already have raised triglycerides tend to be the most sensitive to it.
Timing matters as much as volume. Because the effect is acute, drinking in the day or two before a blood draw can lift the result noticeably, which is one of the more common reasons a reading comes back higher than expected in someone who has otherwise changed nothing. If you want a result that reflects your usual physiology, it is sensible to avoid alcohol for at least a couple of days before testing and to note honestly what you drank if you did not.
For anyone whose result sits above the optimal range, a genuine break from alcohol is informative. Removing alcohol completely for several weeks, keeping everything else steady, then retesting gives a clean read on how much of the number belongs to drinking. That is a far better answer than guessing, and it is the same test-rather-than-assume logic FitScript applies across its panels.
Related: Does Alcohol Increase Triglycerides? (What Labs Show)
Regular aerobic exercise has the strongest and best-documented effect, with resistance training adding useful benefit through its influence on muscle mass and insulin sensitivity.
Aerobic work lowers triglycerides through two routes. During and after exercise, muscle increases its uptake and oxidation of circulating fatty acids, and the enzyme that clears triglyceride from the blood becomes more active in trained muscle. The effect of a single session is real but temporary, typically fading within a day or two, which is why frequency matters more than the occasional long effort. Three to five sessions a week of sustained moderate activity, or a mix of moderate work and shorter higher-intensity intervals, suits most people who are medically cleared to train.
Resistance training contributes differently. Building and maintaining muscle increases the tissue available to dispose of glucose and fatty acids, which improves insulin sensitivity over time and addresses one of the upstream drivers rather than the number itself.
The underrated factor is everything outside formal training. Long uninterrupted sitting reduces the activity of lipoprotein lipase, so breaking up sedentary periods with short walks has a measurable effect on how well fat is cleared after meals. A walk after your largest meal of the day is one of the simplest habits available, and it targets exactly the post-meal window where triglyceride-rich particles accumulate[12]. In a laboratory study, walking after a meal lowered the triglyceride response compared with sitting or standing.[12]
Yes. Loss of excess body fat, particularly visceral fat around the abdomen and in the liver, is one of the most dependable ways to bring triglycerides down, and the response often begins before much weight is lost.
Visceral fat is metabolically active and drains directly into the portal circulation, delivering fatty acids straight to the liver. The more of it there is, the more substrate the liver has for VLDL production. Reducing it lowers that supply and tends to improve insulin sensitivity at the same time, which helps clearance as well. Fat accumulation within the liver itself follows a similar pattern and is closely tied to triglyceride output.
What is encouraging is that the marker often improves in the early stages of a calorie deficit, before the scale has moved much, because the liver responds quickly to reduced energy intake and reduced carbohydrate load. That early feedback can be motivating, although it also means a short burst of effort can flatter a test. Sustained change, measured over months rather than weeks, is the honest assessment.
One caveat worth knowing. During rapid weight loss, large amounts of fatty acid are mobilised from fat stores, and some people see a temporary rise before the downward trend establishes. Testing in the middle of a very aggressive deficit can therefore produce a confusing snapshot.
Triglycerides respond faster than most lipid markers, and meaningful change is commonly visible within a few weeks of consistent effort rather than many months.
The timeline runs on several clocks at once. The acute clock covers hours, where a single meal or drinking session shifts the number. The short clock covers days to a couple of weeks, where removing alcohol and sugary drinks and correcting a clear calorie surplus produce visible movement. The slower clock covers one to three months and beyond, where fat loss, improved insulin sensitivity and training adaptation consolidate the change into something stable.
For retesting, allowing at least six to eight weeks of consistent change before drawing blood again is reasonable for most people, because it gives the slower adaptations time to show up and reduces the chance of measuring a temporary blip. Retesting too soon tends to produce noise rather than signal.
Day-to-day variability in this marker is genuinely high, higher than for LDL or HDL cholesterol. That has a practical consequence. A single result should be treated as one data point, and a trend across several results under comparable conditions tells you far more than any individual reading. Keeping the conditions similar each time, the same fasting status, similar alcohol exposure, similar recent activity, makes the trend interpretable.
Several medical and physiological factors can raise triglycerides independently of what you eat, which is why a result that will not budge despite genuine effort deserves a proper look rather than more willpower.
Reduced thyroid function slows lipid clearance and can lift triglycerides. Poorly controlled diabetes does the same through insulin's role in lipid handling. Chronic kidney disease and nephrotic syndrome are recognised contributors, as is significant liver disease. Pregnancy raises triglycerides as a normal physiological adaptation, with levels rising through the later stages.
Medications matter too. Several drug classes are associated with higher triglycerides. This is not a reason to stop any prescribed medication. It is a reason to mention the finding to the prescriber, who can weigh the benefit of the drug against the lipid effect and decide whether any change is appropriate.
Genetics sets the floor. Familial hypertriglyceridaemia and related inherited disorders of lipoprotein metabolism can produce high values in people whose habits are excellent, and they are a common feature behind the very high readings that carry pancreatitis risk. A strong family history of high triglycerides, early heart disease or pancreatitis is worth raising with a clinician, since it changes how aggressively the finding is investigated[10].
Not always. Both fasting and non-fasting measurements are used, and each answers a slightly different question.
The traditional approach asks for roughly 9 to 12 hours without food, which removes the contribution of the most recent meal and produces a value comparable with the fasting reference ranges most laboratories print. If your result is being tracked over time, or if a clinician is applying fasting thresholds, a fasting sample keeps the comparison clean.
Non-fasting measurement has gained ground because most people spend most of their day in the fed state, and the post-meal period is when triglyceride-rich remnants are highest. Research examining fasting, non-fasting and post-meal values suggests that non-fasting measurement is practical for screening and retains its relationship with cardiometabolic risk[11], and reviews comparing the two states reach broadly similar conclusions about their clinical usefulness[9].
What matters most in practice is consistency and honesty about the conditions. A non-fasting sample taken two hours after a large meal will read higher than a fasting one, and comparing that result to a previous fasting value will suggest a deterioration that may not exist. Water is fine during a fast. Alcohol in the preceding days, an unusually large meal the night before, acute illness, and very intense exercise within the previous day can all nudge the result, so it is worth mentioning any of these when you discuss the report.
Triglycerides are far more informative when read next to the markers that share their underlying biology, which is why they almost never appear on a panel alone.
HDL cholesterol is the most closely linked partner. The two tend to move in opposite directions, because the same enzymatic machinery that handles triglyceride-rich particles also influences HDL. The ratio between triglycerides and HDL is widely used as a rough indicator of insulin resistance and small dense LDL particles, and it often tells you more than either number alone.
Fasting glucose and fasting insulin address the upstream driver directly. If insulin is elevated while glucose still looks acceptable, that pattern frequently explains a stubborn triglyceride result better than anything in the diet history. HbA1c adds a longer-term view of blood sugar.
Beyond that, a full lipid picture is useful. Non-HDL cholesterol captures all the atherogenic particles including remnants, and apolipoprotein B counts the particles themselves, which is valuable because triglycerides and LDL cholesterol can both mislead about particle number. Liver enzymes are worth including, since fatty liver and raised triglycerides travel together. Thyroid markers and kidney function help rule in or out the secondary causes described above. FitScript's membership covers 150+ biomarkers tested per year, which is what allows this kind of marker cluster to be read together rather than one result at a time, with Atlas, FitScript's AI health advisor, interpreting the pattern.
When the number stays elevated despite genuine and sustained lifestyle change, or when it is high enough to raise concern about pancreatitis, a licensed provider evaluates whether medical treatment is appropriate.
The first step is usually investigation rather than prescription. That means confirming the result on a repeat sample, checking for secondary causes such as thyroid, kidney or blood sugar problems, reviewing current medications, and taking a family history. Treating an underlying cause often resolves the lipid finding without any lipid-specific drug.
Where medication is considered, a clinician weighs several prescription options. Clinical reviews discuss how the choice depends on how high the level is, whether the priority is reducing cardiovascular risk or reducing pancreatitis risk, and what else is present on the panel[2],[10].
No dose, schedule or product recommendation belongs in an article like this one. Which treatment is suitable, if any, is a clinical decision made by a licensed provider who has reviewed your results, your history and your other medications. Over-the-counter fish oil products vary widely in content and purity and are also worth discussing rather than self-selecting, particularly alongside blood-thinning medication.
Any result outside your laboratory's reference range is worth discussing with a clinician or licensed provider, and some situations warrant doing so promptly rather than at the next routine appointment.
Seek advice promptly if your triglycerides are very high, if you have abdominal pain alongside a high reading, if you have known diabetes that is not well controlled, or if you are pregnant and have a raised result. A markedly elevated value is associated with pancreatitis risk, and that assessment should not wait.
Book a conversation in the normal course if your result sits above the range on two separate tests, if it is rising across several panels even while technically normal, if you have a family history of early heart disease or pancreatitis, if you take a medication known to raise lipids, or if the number has not responded to several months of genuine lifestyle change.
What to bring is straightforward. Your recent results with dates and fasting status, an honest account of alcohol intake, a list of all medications and supplements, any relevant family history, and a note of what you have already changed. Never ignore an abnormal result and never stop a prescribed medication on the basis of a single lipid value. The useful outcome of a conversation like this is a clear plan for what to retest, when, and what to investigate alongside it.
For a deeper look at the individual markers discussed here, see Triglycerides, hdl cholesterol and the triglyceride hdl ratio, along with fasting glucose and fasting insulin for the metabolic side of the picture. These markers are tested together on FitScript's Heart Health panel.
Start by removing alcohol, sugar-sweetened drinks and refined carbohydrate, correcting any calorie surplus, and adding regular aerobic exercise plus resistance training. Losing excess abdominal fat helps considerably. If the value stays high despite months of consistent change, a clinician should check for thyroid, kidney, blood sugar, medication and genetic causes before considering treatment.
The highest-yield changes are cutting added sugar and alcohol, replacing refined starches with higher-fibre whole foods, eating oily fish regularly, and training most days of the week. Breaking up long periods of sitting also improves how efficiently your body clears circulating fat. Retest after six to eight weeks of consistent effort to see the trend.
You reduce them by lowering the supply of fat the liver exports and improving how fast tissues clear it. Practically, that means less alcohol and refined carbohydrate, a calorie intake matched to your activity, loss of excess body fat, and regular exercise. Treating any underlying cause, such as low thyroid function, matters just as much.
Focus on four levers. Remove alcohol and liquid sugar, correct a calorie surplus, build regular aerobic and resistance training into the week, and reduce excess visceral fat. Then retest under the same conditions to confirm the direction. If the number resists all of that, discuss further investigation with a clinician or licensed provider.
Most laboratories treat fasting values below 150 mg/dL as normal, with a typical reference range of 30 to 150 mg/dL. FitScript's optimal range is 50 to 80 mg/dL, which is an optimization target rather than a diagnostic cut-off. Ranges vary by laboratory, age and sex, so read your result against the range printed on your own report.
Faster than most lipid markers. Removing alcohol and sugary drinks can shift the number within days to a couple of weeks, while fat loss and improved insulin sensitivity consolidate the change over one to three months. Allow at least six to eight weeks of consistent effort before retesting so you measure a trend rather than noise.
Not necessarily. Fasting samples, usually after 9 to 12 hours without food, match the fasting reference ranges laboratories print and keep comparisons clean over time. Non-fasting measurement is also used for screening and reflects the fed state most people spend their day in. Whichever you choose, keep the conditions consistent between tests.
HDL cholesterol, the triglyceride to HDL ratio, fasting glucose, fasting insulin and HbA1c cover the metabolic drivers. Apolipoprotein B and non-HDL cholesterol give a fuller picture of atherogenic particles, while liver enzymes, thyroid markers and kidney function help identify secondary causes. Reading these together is far more informative than any single value.
Yes. Several prescription options are available to a clinician, usually considered after confirming the result and ruling out secondary causes. A licensed provider evaluates whether any treatment is appropriate based on your full results, history and current medications. Dosing and product choice are clinical decisions, not self-selected ones.